
Soumeet Sarkar
Soumeet Sarkar is an experienced financial journalist and research analyst with extensive expertise in Indian equity markets, corporate developments and sectoral trends. Known for his data-driven a...
Stories By Soumeet Sarkar
Blackstone To Pick Up 15.7% In IIFL Finance Via Rs 5,000-Crore Bet At Rs 602/ShareIIFL Finance's board has also approved the preferential issue of 8.55 crore compulsorily convertible preference shares (CCPS), and 2.1 crore warrants at Rs 602 apiece.
November Market Trends: HAL To Vodafone Idea Stocks That Consistently Gave Positive Returns Over A DecadeThe Nifty Midcap 100 delivered an average return of 2.7% in November, while the Nifty Smallcap 100 averaged 2% over the 10-year period.
Reliance Industries Q2 Preview: Will O2C Strength Offset Retail And Oil & Gas Weakness?Reliance Industries' oil and gas exploration business is expected to report flat Ebitda of Rs 4,973 crore, unchanged from the previous quarter.
Jio Platforms IPO SWOT: Can Rs 10.3 Lakh Crore Valuation Hold? What Investors Must Know About Strengths & RisksThe combination of scale, infrastructure and customer reach gives Jio Platforms an established base from which to pursue growth in adjacent businesses.
Ola Electric Shares Downgraded To Sell, Target Price Cut, Here's What Worries Goldman SachsGoldman Sachs said Ola Electric's path to sustainable free cash flow generation has become less clear, given relatively high interest costs and capital expenditure requirements across its battery cell and electric two-wheeler businesses.
Jio IPO Price Band, Valuation: What It Means For RIL And Bharti AirtelA strong Jio Platforms listing could provide a positive read-through for telecom-sector sentiment. Conversely, a muted debut or sustained pressure on Jio's shares could limit hopes of a sector-wide re-rating.
Air Traffic Growth Hits Turbulence: Why India's Domestic Passenger Numbers Are FallingThe consecutive declines in the past four months raise questions over whether India's aviation boom is entering a temporary period of capacity and demand adjustment.
RBI Rate Hike Playbook: PNB, Axis, Others Poised To Gain As Morgan Stanley Picks Top Banking, HFC WinnersAccording to Morgan Stanley estimates, banks with a higher share of repo-linked loans are likely to benefit the most from a 25-basis-point increase.
Nephroplus Block Deal: Investcorp, Bessemer, Promoters Likely To Offload Stake In Up To Rs 650-Crore SaleThe offer price has been set at Rs 705 per share, representing a 5% discount to Nephrocare Health Services' closing price of Rs 741.90 on Wednesday.
Sedemac Block Deal: HDFC Life Among Three Holders Likely To Sell Rs 1,330-Crore StakeA91 Emerging Fund, Xponentia Opportunities Fund and HDFC Life are likely to be among the sellers.
Pine Labs Block Deal: Mastercard Asia-Pacific To Exit With Rs 890-Crore Stake SaleThe floor price represents a 7.33% discount to Pine Labs' previous closing price of Rs 193.70 per share.
What Happens If US Imposes 100% Tariff On Russian Oil Buyers? IOCL, BPCL & HPCL Face RiskThe Lindsey Graham Sanctioning Russia and Iran Act of 2026, signed into law by US President Donald Trump on September 18, authorises tariffs of up to 100% on countries among the largest buyers of Russian energy.
Lenskart Block Deal: ADIA Arm To Sell Rs 2,047-Crore Stake At 3.5% Discount, Say SourcesPlatinum Jasmine A will sell shares equivalent to a 1.7% stake in the eyewear retailer.
Cochin Shipyard In Focus: Govt OFS Not On The Cards, Says ManagementCochin Shipyard has recently entered into a 50:50 joint venture with DP World's Drydocks World to operate and expand the International Ship Repair Facility in Kochi.
NSE IPO Risks: Retail F&O Reliance, Expiry-Day Jitters Among 7 Potential Headwinds For InvestorsThe critical variables to monitor will therefore be regulatory policy, F&O volumes, retail participation, market share, revenue diversification and NSE's ability to maintain its technological edge.
NSE IPO: Where World's 7th Largest Exchange Will Stand Vis-A-Vis Nasdaq Post D-Street DebutNSE is set to command a valuation that places it among the world's most valuable listed exchange operators, although its valuation multiple remains significantly higher than those of most global peers.
Biocon Block Deal: True North Likely To Sell Rs 640-Crore Stake, Sources SayTrue North is likely to offload 1.7 crore Biocon shares at Rs 385 apiece, a 2% discount to the current market price.
Coal India 2.0: From Coal Giant To Holding Company?On Dalal Street, pure holding companies are generally assigned a discount of 25% to 50%.This risk is now relevant for Coal India.
Gland Pharma Promoter Likely To Sell 5% Stake Via Rs 2,279 Crore Block DealFosun Pharma Industrial held a 51.77% stake in Gland Pharma as of June, making it the company's largest shareholder.
Meesho Block Deal: SoftBank Likely To Sell Rs 1,435 Crore Stake At 3% DiscountSoftBank'sspecial purpose investment vehicle and subsidiary SVF II Meerkat DE is looking to sell 7 crore shares for a floor price of Rs 205 per share.